<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li RHL</submitter><funding>Maxine Adler Graduate Fellowship for Eric Ontiveros</funding><funding>Center for Companion Animal Health, University of California, Davis</funding><pagination>2438-2446</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7694846</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>A nonpedigreed male cat presented with epistaxis, severe bladder hemorrhage, and secondary urethral obstruction after cystocentesis.&lt;h4>Objectives&lt;/h4>To characterize the phenotype of a cat with bleeding diathesis and use a precision medicine approach to identify the molecular genetic defect by whole genome sequencing.&lt;h4>Methods&lt;/h4>Adenosine diphosphate (ADP) and arachidonic acid (AA)-induced whole blood platelet aggregometry was performed in the affected cat and a healthy cat. Platelet activation, measured by P-selectin expression, and surface integrin subunit β3 expression were evaluated by flow cytometry in the affected cat and healthy control. Total integrin subunit αIIb expression was assessed by western blot. Whole genome sequencing at 30× coverage was used to id</pubmed_abstract><journal>Journal of veterinary internal medicine</journal><pubmed_title>Precision medicine identifies a pathogenic variant of the ITGA2B gene responsible for Glanzmann's thrombasthenia in a cat.</pubmed_title><pmcid>PMC7694846</pmcid><funding_grant_id>2019-30-F</funding_grant_id><pubmed_authors>99 Lives Cat Genome Consortium</pubmed_authors><pubmed_authors>Stern JA</pubmed_authors><pubmed_authors>Li RHL</pubmed_authors><pubmed_authors>Hardy BT</pubmed_authors><pubmed_authors>Nguyen N</pubmed_authors><pubmed_authors>Ontiveros E</pubmed_authors><pubmed_authors>Lee E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Precision medicine identifies a pathogenic variant of the ITGA2B gene responsible for Glanzmann's thrombasthenia in a cat.</name><description>&lt;h4>Background&lt;/h4>A nonpedigreed male cat presented with epistaxis, severe bladder hemorrhage, and secondary urethral obstruction after cystocentesis.&lt;h4>Objectives&lt;/h4>To characterize the phenotype of a cat with bleeding diathesis and use a precision medicine approach to identify the molecular genetic defect by whole genome sequencing.&lt;h4>Methods&lt;/h4>Adenosine diphosphate (ADP) and arachidonic acid (AA)-induced whole blood platelet aggregometry was performed in the affected cat and a healthy cat. Platelet activation, measured by P-selectin expression, and surface integrin subunit β3 expression were evaluated by flow cytometry in the affected cat and healthy control. Total integrin subunit αIIb expression was assessed by western blot. Whole genome sequencing at 30× coverage was used to id</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Nov</publication><modification>2026-05-02T19:19:51.582Z</modification><creation>2021-02-20T07:41:47Z</creation></dates><accession>S-EPMC7694846</accession><cross_references><pubmed>32935881</pubmed><doi>10.1111/jvim.15886</doi></cross_references></HashMap>